Yüklüyor......
Recent advances of glucocorticoids in the treatment of Duchenne muscular dystrophy (Review)
Duchenne muscular dystrophy (DMD) is the most common degenerative neuromuscular disease. The incidence of DMD in live births is 1/3,600-1/6,000. Although glucocorticoid-dependent medication is the mainstay treatment option for DMD, a standard treatment regimen has yet to be determined. The present r...
Kaydedildi:
| Yayımlandı: | Exp Ther Med |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
D.A. Spandidos
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7967797/ https://ncbi.nlm.nih.gov/pubmed/33777191 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2021.9875 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|